Understanding what makes a gene therapy program commercially viable

Time: 10:40 am
day: decision makers day - track b

Details:

Topics to be Discussed:

Identifying viable target disease areas

Maintaining a treatment-eligible patient pool through development and post-launch

Discussing and brainstorming solutions for key limiting factors in the overall cost of commercializing a gene therapy

Defining fair treatment prices

Speakers:

Lawrence Kau Lawrence has spent the majority of his more than 20 years in the biotech industry working in rare genetic diseases and gene therapies. In his Read more